Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma
Clinical trial NCT06418724 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06418724
- Sponsor
- Melanoma and Skin Cancer Trials Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2026-07-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.